Open Access
| Issue |
Med Sci (Paris)
Volume 41, Number 11, Novembre 2025
|
|
|---|---|---|
| Page(s) | 853 - 855 | |
| Section | Nouvelles | |
| DOI | https://doi.org/10.1051/medsci/2025217 | |
| Published online | 12 December 2025 | |
- Stevanin G, Santorelli FM, Azzedine H, et al. Mutations in SPG11, encoding spatacsin, are a major cause of spastic paraplegia with thin corpus callosum. Nat Genet 2007; 39 : 366-72. [Google Scholar]
- Stevanin G, Azzedine H, Denora P, et al. Mutations in SPG11 are frequent in autosomal recessive spastic paraplegia with thin corpus callosum, cognitive decline and lower motor neuron degeneration. Brain 2008 ; 131 : 772-84. [Google Scholar]
- Méreaux JL, Banneau G, Papin M, et al. Clinical and genetic spectra of 1550 index patients with hereditary spastic paraplegia. Brain 2022 ; 145 : 1029-37. [Google Scholar]
- Murmu RP, Martin E, Rastetter A, et al. Cellular distribution and subcellular localization of spatacsin and spastizin, two proteins involved in hereditary spastic paraplegia. Mol Cell Neurosci 2011 ; 47 : 191-202. [Google Scholar]
- Hirst J, Edgar JR, Esteves T, et al. Loss of AP-5 results in accumulation of aberrant endolysosomes: defining a new type of lysosomal storage disease. Hum Mol Genet 2015 ; 24 : 4984-96. [Google Scholar]
- Denton K, Mou Y, Xu C-C, et al. Impaired mitochondrial dynamics underlie axonal defects in hereditary spastic paraplegias. Hum Mol Genet 2018 ; 27 : 2517-30. [Google Scholar]
- Chen Z, Chai E, Mou Y, et al. Inhibiting mitochondrial fission rescues degeneration in hereditary spastic paraplegia neurons. Brain 2022 ; 145 : 4016-31. [Google Scholar]
- Martin E, Yanicostas C, Rastetter A, et al. Spatacsin and spastizin act in the same pathway required for proper spinal motor neuron axon outgrowth in zebrafish. Neurobioly Dis 2012 ; 48 : 299-308. [Google Scholar]
- Branchu J, Boutry M, Sourd L, et al. Loss of spatacsin function alters lysosomal lipid clearance leading to upper and lower motor neuron degeneration. Neurobiol Dis 2017 ; 102 : 21-37. [Google Scholar]
- Boutry M, Branchu J, Lustremant C, et al. Inhibition of lysosome membrane recycling causes accumulation of gangliosides that contribute to neurodegeneration. Cell Reports 2018 ; 23 : 3813-26. [Google Scholar]
- Vantaggiato C, Guarato G, Brivio F, et al. Naringenin and SMER28 target lysosomal reformation and rescue SPG11 and SPG15 hereditary spastic paraplegia phenotypes. Pharmacol Res 2025 ; 218 : 107836. [Google Scholar]
- Fortier M, Cauhapé M, Buono S, et al. Decreasing ganglioside synthesis delays motor and cognitive symptom onset in Spg11 knockout mice. Neurobiol Dis 2024 ; 199 : 106564. [Google Scholar]
- Toupenet Marchesi L, Stockholm D, Esteves T, et al. Transcriptomic analysis reinforces the implication of spatacsin in neuroinflammation and neurodevelopment. Sci Rep 2025 ; 15 : 2370. [Google Scholar]
- Hörner M, Groh J, Klein D, et al. CNS-associated T-lymphocytes in a mouse model of hereditary spastic paraplegia type 11 (SPG11) are therapeutic targets for established immunomodulators. Exp Neurol 2022 ; 355 : 114119. [Google Scholar]
- Hörner M, Popp S, Branchu J, et al. Clinically approved immunomodulators ameliorate behavioral changes in a mouse model of hereditary spastic paraplegia type 11. Front Neurosci 2024 ; 18 : 1299554. [Google Scholar]
- Pozner T, Schray A, Regensburger M, et al. Tideglusib rescues neurite pathology of SPG11 iPSC-derived cortical neurons. Front Neurosci 2018 ; 12 : 914. [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.